Clay M. Anderson

439 total citations
13 papers, 296 citations indexed

About

Clay M. Anderson is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Clay M. Anderson has authored 13 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Clay M. Anderson's work include Cutaneous Melanoma Detection and Management (4 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Clay M. Anderson is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), CAR-T cell therapy research (3 papers) and Immunotherapy and Immune Responses (3 papers). Clay M. Anderson collaborates with scholars based in United States, Australia and Italy. Clay M. Anderson's co-authors include Diane E. Lorant, W.E. Benitz, Merton Bernfield, Richard T. Kelley, Julie A. Ellerhorst, Antônio C. Buzaid, Lajos Pusztai, J. Lynn Palmer, Fernando Cabanillas and Ronald S. Walters and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Clay M. Anderson

13 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clay M. Anderson United States 9 134 98 73 48 48 13 296
Keizo Tokumo Japan 8 141 1.1× 209 2.1× 40 0.5× 27 0.6× 81 1.7× 12 369
M K Heatley United Kingdom 11 83 0.6× 62 0.6× 31 0.4× 28 0.6× 36 0.8× 17 258
Harald Voth Germany 9 95 0.7× 140 1.4× 54 0.7× 33 0.7× 78 1.6× 16 319
H. Eugene Liu Taiwan 10 124 0.9× 260 2.7× 69 0.9× 48 1.0× 56 1.2× 16 436
Jodi A. McKenzie United States 8 121 0.9× 155 1.6× 73 1.0× 81 1.7× 54 1.1× 30 302
Л. А. Коломиец Russia 13 118 0.9× 196 2.0× 37 0.5× 78 1.6× 99 2.1× 95 426
Marco Venanzoni Italy 9 135 1.0× 220 2.2× 28 0.4× 40 0.8× 95 2.0× 12 378
P. G. Knapstein Germany 10 139 1.0× 84 0.9× 33 0.5× 19 0.4× 82 1.7× 24 339
D-S Bae South Korea 9 72 0.5× 130 1.3× 62 0.8× 27 0.6× 63 1.3× 20 372
Naohito Yoshizaki Japan 8 41 0.3× 109 1.1× 76 1.0× 45 0.9× 43 0.9× 23 320

Countries citing papers authored by Clay M. Anderson

Since Specialization
Citations

This map shows the geographic impact of Clay M. Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clay M. Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clay M. Anderson more than expected).

Fields of papers citing papers by Clay M. Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clay M. Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clay M. Anderson. The network helps show where Clay M. Anderson may publish in the future.

Co-authorship network of co-authors of Clay M. Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Clay M. Anderson. A scholar is included among the top collaborators of Clay M. Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clay M. Anderson. Clay M. Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Morton, Donald L., Nicola Mozzillo, Mohammed Kashani–Sabet, et al.. (2012). Long-term cure after complete resection and adjuvant immunotherapy for distant melanoma metastases.. Journal of Clinical Oncology. 30(15_suppl). 8534–8534. 1 indexed citations
2.
Anderson, Clay M., Marian L. Smith, Dong Pil Yoon, & Brick Johnstone. (2012). Relationships among Health and Spiritual Beliefs, Religious Practices, and Congregational Support in Individuals with Cancer. 1(4). 76–80. 2 indexed citations
3.
Koyanagi, Kazuo, Steven O’Day, Peter D. Boasberg, et al.. (2010). Serial Monitoring of Circulating Tumor Cells Predicts Outcome of Induction Biochemotherapy plus Maintenance Biotherapy for Metastatic Melanoma. Clinical Cancer Research. 16(8). 2402–2408. 52 indexed citations
4.
O’Day, Steven, Michael B. Atkins, Peter D. Boasberg, et al.. (2009). Phase II Multicenter Trial of Maintenance Biotherapy After Induction Concurrent Biochemotherapy for Patients With Metastatic Melanoma. Journal of Clinical Oncology. 27(36). 6207–6212. 33 indexed citations
5.
Malhotra, Vikas, et al.. (2004). Neoadjuvant and Adjuvant Chemotherapy with Doxorubicin and Docetaxel in Locally Advanced Breast Cancer. Clinical Breast Cancer. 5(5). 377–384. 17 indexed citations
6.
Anderson, Clay M., et al.. (2003). Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma. Seminars in Oncology. 30(3). 369–374. 13 indexed citations
7.
Fu, Mei R., Clay M. Anderson, Roxanne W. McDaniel, & Jane M. Armer. (2002). Patients' Perceptions of Fatigue in Response to Biochemotherapy for Metastatic Melanoma: A Preliminary Study. Oncology nursing forum. 29(6). 961–966. 13 indexed citations
8.
Buzaid, Antônio C. & Clay M. Anderson. (2000). The changing prognosis of melanoma. Current Oncology Reports. 2(4). 322–328. 18 indexed citations
9.
Anderson, Clay M., et al.. (1999). Primary Myeloid Leukemia Presenting Concomitantly with Primary Multiple Myeloma: Two Cases and an Update of the Literature. Leukemia & lymphoma. 32(3-4). 385–390. 6 indexed citations
10.
Anderson, Clay M., Lajos Pusztai, J. Lynn Palmer, Fernando Cabanillas, & Julie A. Ellerhorst. (1998). COINCIDENT RENAL CELL CARCINOMA AND NONHODGKIN'S LYMPHOMA: THE M.D. ANDERSON EXPERIENCE AND REVIEW OF THE LITERATURE. The Journal of Urology. 159(3). 714–717. 52 indexed citations
11.
Anderson, Clay M., Antônio C. Buzaid, & Elizabeth A. Grimm. (1996). Interaction of Chemotherapy and Biological Response Modifiers in the Treatment of Melanoma. Cancer treatment and research. 87. 357–380. 2 indexed citations
12.
Anderson, Clay M., Ronald S. Walters, & Gabriel N. Hortobágyi. (1996). Mediastinitis Related to Probable Central Vinblastine Extravasation in a Woman Undergoing Adjuvant Chemotherapy for Early Breast Cancer. American Journal of Clinical Oncology. 19(6). 566–568. 18 indexed citations
13.
Benitz, W.E., Richard T. Kelley, Clay M. Anderson, Diane E. Lorant, & Merton Bernfield. (1990). Endothelial Heparan Sulfate Proteoglycan. I. Inhibitory Effects on Smooth Muscle Cell Proliferation. American Journal of Respiratory Cell and Molecular Biology. 2(1). 13–24. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026